Memories of my research into von Willebrand's disease

Haemophilia

Volumn 18, Issue 1, 2012, Pages 3-6

  Blomback M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; FIBRINOGEN;

APPENDECTOMY; ARTICLE; BLEEDING TIME; BLOOD ANALYSIS; BLOOD TRANSFUSION; GENE MUTATION; HEMOPHILIA; HUMAN; MEDICAL RESEARCH; MENORRHAGIA; PRIORITY JOURNAL; VON WILLEBRAND DISEASE;

BIOMEDICAL RESEARCH; FACTOR VIII; HISTORY, 20TH CENTURY; HUMANS; VON WILLEBRAND DISEASES; VON WILLEBRAND FACTOR;

EID: 84255195601     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2011.02718.x     Document Type: Article

References (18)

1. Blombäck B. A journey with bleeding time factor. Semenza G ed. Comprehensive Biochemistry Stories of Success - Personal Recollections, DOI:10.1016/S0069-8032(07)45006-9. Amsterdam: Elsevier B. V., 2007: 209-55.
2. Blombäck B, Blombäck M. Purification of human and bovine fibrinogen. Arkiv Kemi 1956; 10: 415-43.
3. Nilsson IM, Blombäck M, von Francken I. On an inherited autosomal hemorrhagic diathesis with antihemophilic globulin (AHG) deficiency and prolonged bleeding time. Acta Med Scand 1957; 59: 35-57.
4. Blombäck M. von Willebrand's disease in Scandinavia and on difficulties in diagnosing von Willebrand's disease type I. Haemostasis 1992; 22: 236-44.
5. Nilsson IM, Blombäck M, Jorpes E, Blombäck B, Johansson S-A. v. Willebrand's disease and its correction with human Fraction I-0. Acta Med Scand 1957; 59: 179-88.
6. Blombäck M. Scientific visits to the Åland islands. Haemophilia 1999; 5(Suppl. 2): 12-4.
7. Blombäck M. Studies on antihemophilic globulin. Thesis summary. Acta Paediatr 1958; 47(Suppl. 114): 1-32. See page 24.
8. th Congr Europ Soc Haemat London 1959 part II, 1960: 587-93.
9. Blombäck M, Blombäck B, Nilsson IM. Further studies on antihemophilic globulin and related substances. Brinkhous KM ed. Hemophilia and Other Hemorrhagic States, Int Symp VII Congr Soc Hematol, Rome, September 1958. Chapel Hill, NC: University of North Carolina Press, 1959: 13-8.
10. Nilsson IM, Blombäck M, Blombäck B. v Willebrand's disease in Sweden: Its treatment and pathogenesis. Acta Med Scand 1959; 164: 263-78.
11. Cornu P, Larrieu M-J, Caen J, Bernard J. Donne'es nouvelles concernant la maladie de Willebrand (Angiohémophilie). Rev Franc Etudes Clin Biol 1960; 5: 614-20.
12. Lehmann W, Juergens J, Eriksson AW. The platelet function of the thrombopathy on the Åland islands. Thromb Diath Haemorrh 1964; 12: 148-68.
13. Nyman D, Eriksson AW, Lehmann W, Blombäck M. Inherited defective aggregation with arachidonate as the main expression of a defective metabolism of arachidonic acid. Thromb Res 1979; 14: 739-46.
14. Nyman D, Eriksson AW, Blombäck M, Frants RR, Wahlberg P. Recent investigations of the first bleeder family in Åland (Finland) described by von Willebrand. Thromb Haemost 1981; 45: 73-6.
15. Nyman D, Blombäck M, Lehmann W, Frants RR, Eriksson AW. Blood coagulation studies in bleeder families on the Åland islands. Sigrid Juselius symposium 1978. Eriksson AW ed. Population Structure and Genetic Disorders. London: Academic Press, 1980; 45: 547-52.
16. Anvret M, Blombäck M, Lindstedt M, Söderlnd E, Tapper-Persson M, Thelander A-C. Genetic and blood coagulation characterization of 'Swedish' families with von Willebrand's disease types I and III: new aspects of heredity. Hum Genet 1992; 89: 147-54.
17. Zhang ZP, Blombäck M, Nyman D, Anvret M. Mutaions of von Willebrand factor gene in families with von Willebrand's disease in the Åland islands. PNAS Genomics 1993; 90: 7937-40.
18. Zhang Z. Characterization of the von Willebrand factor gene in von Willebrand disease types 1 and 3 patients. PhD Thesis. Karolinska Institutet, Stockholm 1995: 1-42. ISBN-91-628-1545-8.